07.12.2016
- French drugs major Sanofi is weighing a rival offer to Johnson & Johnson’s recent bid for Swiss pharmaceuticals and biotech firm Actelion, the news agency Bloomberg has reported...
05.12.2016
- Pfizer Venture Investments (PVI) and TVM Life Science Ventures VII are making an additional $12 million investment in Ixchelsis. This funding will enable the UK start-up company to...
29.11.2016
- Major US healthcare company Johnson & Johnson (J&J) is holding preliminary talks with Swiss pharmaceuticals and biotechnology firm Actelion about a potential takeover. An...
11.11.2016
- US drug major Pfizer is looking at divesting its $3.5 billion consumer health unit to free up $14 billion in cash, the news agency Reuters has reported, quoting anonymous sources...
10.11.2016
- Major US drugmaker Pfizer has announced plans to close two of its three sites in the UK, although it insists the decision is not a result of Brexit, according to media reports. The...
25.10.2016
- Major drugmakers Merck KGaA of Germany and Pfizer of the US are collaborating with Debiopharm International, a drug developer based in Lausanne, Switzerland to study the potential...
17.10.2016
- Pifzer has lost its appeal of a UK patent dispute with Allergan over Lyrica, one of the US pharmaceutical giant blockbuster drugs, with annual global sales of around $5 billion. It...
10.10.2016
- Pfizer is selling its global infusion therapy business, Hospira Infusion Systems (HIS), to ICU Medical for $1 billion. The proposed merger will create a leading infusion therapy...
